title: Long-term home cage activity scans reveal lowered exploratory behaviour in symptomatic female Rett mice.
abstract: Numerous experimental models have been developed to reiterate endophenotypes of Rett syndrome, a neurodevelopmental disorder with a multitude of motor, cognitive and vegetative symptoms. Here, female Mecp2(Stop) mice [1] were characterised at mild symptomatic conditions in tests for anxiety (open field, elevated plus maze) and home cage observation systems for food intake, locomotor activity and circadian rhythms. Aged 8-9 months, Mecp2(Stop) mice presented with heightened body weight, lower overall activity in the open field, but no anxiety phenotype. Although home cage activity scans conducted in two different observation systems, PhenoMaster and PhenoTyper, confirmed normal circadian activity, they revealed severely compromised habituation to a novel environment in all parameters registered including those derived from a non-linear decay model such as initial exploration maximum, decay half-life of activity and span, as well as plateau. Furthermore, overall activity was significantly reduced in nocturnal periods due to reductions in both fast ambulatory movements, but also a slow lingering. In contrast, light-period activity profiles during which the amount of sleep was highest remained normal in Mecp2(Stop) mice. These data confirm the slow and progressive development of Rett-like symptoms in female Mecp2(Stop) mice resulting in a prominent reduction of overall locomotor activity, while circadian rhythms are maintained. Alterations in the time-course of habituation may indicate deficiencies in cognitive processing.
authors: School of Medical Science, College of Life Science and Medicine, University of Aberdeen, Aberdeen, AB25 2ZD Scotland, UK.
authors: Lianne
authors: L
authors: Robinson
authors: Andrea
authors: A
authors: Plano
authors: Stuart
authors: S
authors: Cobb
authors: Gernot
authors: G
authors: Riedel
mesh_terms: D000818:Animals; D001007:Anxiety / Q000209:etiology / Q000235:genetics; D001835:Body Weight / Q000235:genetics; D002940:Circadian Rhythm / Q000235:genetics; D004195:Disease Models, Animal; D018450:Disease Progression; D004777:Environment; D005106:Exploratory Behavior / Q000502:physiology*; D005260:Female; D018782:Maze Learning / Q000502:physiology; D051783:Methyl-CpG-Binding Protein 2 / Q000235:genetics; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009043:Motor Activity / Q000235:genetics; D009154:Mutation / Q000235:genetics; D010641:Phenotype; D015518:Rett Syndrome / Q000235:genetics / Q000503:physiopathology*
chemical_list: C497393:Mecp2 protein, mouse; D051783:Methyl-CpG-Binding Protein 2
references: Hum Mol Genet. 2008 Jun 15;17(12):1707-17
references: 18321865
references: Physiol Res. 2003;52(1):53-60
references: 12625807
references: Nat Genet. 2001 Mar;27(3):322-6
references: 11242117
references: Biol Psychiatry. 2010 Apr 1;67(7):657-65
references: 20172507
references: Clin Electroencephalogr. 2001 Jan;32(1):20-3
references: 11202137
references: Brain. 2012 Sep;135(Pt 9):2699-710
references: 22525157
references: Hum Mol Genet. 2007 Oct 1;16(19):2315-25
references: 17635839
references: Neuroscience. 2007 May 25;146(3):907-21
references: 17383101
references: Hum Mol Genet. 2005 Jul 1;14(13):1851-61
references: 15888476
references: Nat Genet. 2001 Mar;27(3):327-31
references: 11242118
references: Behav Brain Res. 2005 May 28;160(2):382-8
references: 15863235
references: Neuropeptides. 2009 Dec;43(6):491-7
references: 19781771
references: Behav Modif. 2007 Jul;31(4):466-87
references: 17548541
references: J Neurosci. 2009 Apr 1;29(13):4218-27
references: 19339616
references: Neuron. 2002 Jul 18;35(2):243-54
references: 12160743
references: Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):18208-13
references: 20921395
references: Science. 2008 May 30;320(5880):1224-9
references: 18511691
references: Hum Mol Genet. 2005 Jan 15;14(2):205-20
references: 15548546
references: J Child Psychol Psychiatry. 2002 Nov;43(8):1099-110
references: 12455930
references: Behav Pharmacol. 2008 Sep;19(5-6):501-17
references: 18690105
references: Br J Pharmacol. 2009 Apr;156(7):1154-66
references: 19378378
references: Nature. 1999 Dec 2;402(6761 Suppl):C25-9
references: 10591222
references: Ann Neurol. 1987 Apr;21(4):377-82
references: 3579223
references: Brain. 2006 Apr;129(Pt 4):887-98
references: 16467389
references: Neuropharmacology. 2013 May;68:174-83
references: 22709945
references: Hum Mol Genet. 2008 Jun 15;17(12):1718-27
references: 18321864
references: Hum Mol Genet. 2013 Jan 1;22(1):96-109
references: 23026749
references: Pediatr Res. 2006 Apr;59(4 Pt 1):513-8
references: 16549521
references: AJR Am J Roentgenol. 1992 Jul;159(1):177-83
references: 1609693
references: Biochem Biophys Res Commun. 2006 Feb 17;340(3):776-83
references: 16380085
references: Brain Dev. 2001 Dec;23 Suppl 1:S118-21
references: 11738856
references: Neuropsychopharmacology. 2012 Apr;37(5):1152-63
references: 22157810
references: Am J Hum Genet. 2004 Mar;74(3):511-20
references: 14973779
references: J Clin Invest. 2006 Jul;116(7):1983-93
references: 16767221
references: Eur Child Adolesc Psychiatry. 1998 Jun;7(2):69-72
references: 9712372
references: Behav Brain Res. 2011 Jan 1;216(1):313-20
references: 20713094
references: Neurobiol Dis. 2006 Aug;23(2):422-32
references: 16766199
references: Nat Neurosci. 2012 Jan 26;15(2):176-7
references: 22281712
references: Nat Genet. 1999 Oct;23(2):185-8
references: 10508514
references: J Pediatr. 2007 Jan;150(1):37-9
references: 17188610
references: Neuron. 2008 Sep 25;59(6):947-58
references: 18817733
references: Ann Neurol. 1983 Oct;14(4):471-9
references: 6638958
references: Eur J Neurosci. 2008 Jun;27(12):3342-50
references: 18557922
references: Ment Retard Dev Disabil Res Rev. 2002;8(2):61-5
references: 12112728
references: Brain Dev. 2007 Nov;29(10):609-16
references: 17531413
references: Genes Brain Behav. 2007 Apr;6(3):277-86
references: 16848781
references: Genes Brain Behav. 2010 Mar 1;9(2):213-23
references: 19958389
references: Ann Neurol. 1993 Aug;34(2):227-34
references: 8338347
references: Hum Mol Genet. 2008 May 15;17(10):1386-96
references: 18223199
references: Hum Mol Genet. 2011 Feb 15;20(4):731-51
references: 21118894
references: Brain Dev. 1990;12(5):488-93
references: 2288379
references: Behav Brain Res. 2005 Jul 30;162(2):272-8
references: 15970221
references: Epigenetics. 2006 Oct-Dec;1(4):e1-11
references: 17486179
references: Science. 2007 Feb 23;315(5815):1143-7
references: 17289941
references: Brain Dev. 2005 Nov;27 Suppl 1:S35-S42
references: 16182496
references: Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18267-72
references: 17108082
references: Proc Natl Acad Sci U S A. 2007 Feb 6;104(6):1931-6
references: 17267601
references: Curr Top Dev Biol. 2004;59:61-86
references: 14975247
references: Biol Psychiatry. 2006 Mar 1;59(5):468-76
references: 16199017
references: Auton Neurosci. 2007 Oct 30;136(1-2):82-9
references: 17544925
references: Am J Med Genet. 2001 Nov 15;104(1):14-22
references: 11746022
references: J Appl Physiol (1985). 2008 Jan;104(1):198-204
references: 18006868